A diagnosis of HER2-positive breast cancer can be frightening at first, especially when you hear the words “aggressive cancer.” But there’s reason to be optimistic about today’s advances ...

Background: Variable rates of HER2 protein overexpression and gene amplification have been reported in advanced ovarian cancers (AOC). Trastuzumab, tested only as a single agent, has been shown to ...

Your doctor has just told you that you have early-stage HER2+ breast cancer. Now what? It may take some time to process your emotions. Yet in most cases, it’s also essential that you make some ...

What is the study about? HER2-RADiCAL is investigating whether some people with HER2 positive breast cancer can safely receive less treatment after surgery. HER2 is a protein which can cause cancer to ...

[59] Thus, there are not enough data to support the use of HER2 as a prognostic marker, or as a predictor for specific chemotherapy protocols/endocrine therapy or for routine detection of serum ...